(Q40573323)

21 September 2017

title

Fusion protein from RGD peptide and Fc fragment of mouse immunoglobulin G inhibits angiogenesis in tumor (English)

1 reference

21 September 2017

Jinhua Li

1

1 reference

21 September 2017

Jianfei Ji

2

1 reference

21 September 2017

Lillia M Holmes

3

1 reference

21 September 2017

Kelly E Burgin

4

1 reference

21 September 2017

Lori B Barton

5

1 reference

21 September 2017

Xianzhong Yu

6

1 reference

21 September 2017

Thomas E Wagner

7

1 reference

21 September 2017

Yanzhang Wei

8

1 reference

21 September 2017

publication date

1 May 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

11

1 reference

21 September 2017

issue

5

1 reference

21 September 2017

page(s)

363-370

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700707

21 September 2017

exact match

0 references

cites work

Mechanisms of angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700707

Angiogenesis and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700707

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700707

Effects of angiogenesis inhibitors on multistage carcinogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700707

Requirement of vascular integrin alpha v beta 3 for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700707

Production of functionalized single-chain Fv antibody fragments binding to the ED-B domain of the B-isoform of fibronectin in Pichia pastoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700707

Alpha v integrins as receptors for tumor targeting by circulating ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700707

Solution structures and integrin binding activities of an RGD peptide with two isomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700707

Anti-cancer activity of targeted pro-apoptotic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700707

Intratumoral injection of adenoviral vectors encoding tumor-targeted immunoconjugates for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700707

Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700707

Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700707

21 January 2018

Identifiers

DOI

10.1038/SJ.CGT.7700707

1 reference

Dimensions Publication ID

21 September 2017

1002519315

0 references

1 reference